chrX-129746609-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_003399.6(XPNPEP2):āc.418A>Gā(p.Ile140Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000051 in 1,177,270 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003399.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XPNPEP2 | NM_003399.6 | c.418A>G | p.Ile140Val | missense_variant | 6/21 | ENST00000371106.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XPNPEP2 | ENST00000371106.4 | c.418A>G | p.Ile140Val | missense_variant | 6/21 | 1 | NM_003399.6 | P1 | |
XPNPEP2 | ENST00000371105.7 | n.658A>G | non_coding_transcript_exon_variant | 6/6 | 2 | ||||
XPNPEP2 | ENST00000681234.1 | n.683A>G | non_coding_transcript_exon_variant | 6/7 |
Frequencies
GnomAD3 genomes AF: 0.0000119 AC: 1AN: 84136Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 22126
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182979Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67493
GnomAD4 exome AF: 0.00000457 AC: 5AN: 1093134Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 1AN XY: 360752
GnomAD4 genome AF: 0.0000119 AC: 1AN: 84136Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 22126
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.418A>G (p.I140V) alteration is located in exon 6 (coding exon 6) of the XPNPEP2 gene. This alteration results from a A to G substitution at nucleotide position 418, causing the isoleucine (I) at amino acid position 140 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at